好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Post-acute neurological sequalae of SARS-COV-2 infection
Infectious Disease
P1 - Poster Session 1 (9:00 AM-5:00 PM)
229

To investigate associations of COVID-19 illness severity in individuals who have developed objective or subjective neurologic findings after infection. 

Following recovery from acute COVID-19 illness many patients report onset of new cognitive and neurological symptoms which can be disabling. 

Early in the pandemic, in response to clinical experience and emerging research on post-acute neurological sequelae (PANS) of COVID-19, we created an IRB-approved patient registry in the Department of Neurology. Participants included are both retrospectively identified patients located through a search of all existing patients from Neurology outpatient practices at Columbia University Irving Medical Center with any COVID-19 related diagnosis, plus newly referred patients with PANS. Those included met CDC criteria of either suspected, probable, or confirmed COVID-19 (N=121). Information was obtained retrospectively through chart review and prospectively through symptom questionnaire and mini-MoCA. Analysis was performed with Chi-squared test and Pearson’s correlation.

Our cohort was  72.7% women, mean age 47.9, 54.2% white, 16.7% Hispanic/Latino, 6.7% Black/African American, and 5% Asian. 55.45% had a prior neurological diagnosis, most commonly headache (23.1%). 68.8% had both clinical and lab definite COVID-19 infection, 23.1% required hospitalization, and 9.1%  ICU care. 72.2% reported no worsening of prior neurological symptoms but 81.8% developed new neurological symptoms including general cognitive complaints (47.9%), attention difficulty (42.1%), word finding difficulty (36.4%), vestibular complaints (23.1%), and fatigue (19.8%). Mini-MoCAs were administered to 37 subjects (median score 12/15).

Hospitalization for COVID-19 correlated with subjective “brain fog” (p= .009) and attention difficulty (p= .011). ICU requirement correlated with subjective word finding difficulty (p= .049), “brain fog” (p= .034), and attention difficulty (p= .020). There was a relationship between length of hospitalization and mini MoCA score (p= .006).

In this patient sample, severity of infection assessed through surrogate measures of hospitalization and ICU requirement are associated with subjective and objective post COVID-19 neurological dysfunction.
Authors/Disclosures
Alanna Balbi, MD
PRESENTER
Dr. Balbi has nothing to disclose.
No disclosure on file
Marianna S. Yugrakh, MD (Columbia University) The institution of Dr. Yugrakh has received research support from Teva.
No disclosure on file
Melodie R. Winawer, MD, MS (Columbia Univ) Dr. Winawer has nothing to disclose.